Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity.
Crouch ER, Kraker RT, Wallace DK, Holmes JM, Repka MX, Collinge JE, Bremer DL, Gray ME, Smith HA, Steinkuller PG; Writing Committee for Pediatric Eye Disease Investigator Group. Crouch ER, et al. Among authors: collinge je. JAMA Ophthalmol. 2020 Jan 1;138(1):14-20. doi: 10.1001/jamaophthalmol.2019.4488. JAMA Ophthalmol. 2020. PMID: 31697304 Free PMC article. Clinical Trial.
The Pediatric Optic Neuritis Prospective Outcomes Study: Two-Year Results.
Pineles SL, Henderson RJ, Repka MX, Heidary G, Liu GT, Waldman AT, Borchert MS, Khanna S, Graves JS, Collinge JE, Conley JA, Davis PL, Kraker RT, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Pineles SL, et al. Among authors: collinge je. Ophthalmology. 2022 Aug;129(8):856-864. doi: 10.1016/j.ophtha.2022.03.021. Epub 2022 Mar 29. Ophthalmology. 2022. PMID: 35364222 Free PMC article.
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.
Freedman SF, Hercinovic A, Wallace DK, Kraker RT, Li Z, Bhatt AR, Boente CS, Crouch ER, Hubbard GB, Rogers DL, VanderVeen D, Yang MB, Cheung NL, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Freedman SF, et al. Ophthalmology. 2022 Oct;129(10):1120-1128. doi: 10.1016/j.ophtha.2022.05.019. Epub 2022 Jun 1. Ophthalmology. 2022. PMID: 35660415 Free PMC article.
Outcome of pediatric patients referred for papilledema.
Kovarik JJ, Doshi PN, Collinge JE, Plager DA. Kovarik JJ, et al. Among authors: collinge je. J AAPOS. 2015 Aug;19(4):344-8. doi: 10.1016/j.jaapos.2015.05.007. Epub 2015 Jul 30. J AAPOS. 2015. PMID: 26235795
Update in pediatric optic neuritis.
Collinge JE, Sprunger DT. Collinge JE, et al. Curr Opin Ophthalmol. 2013 Sep;24(5):448-52. doi: 10.1097/ICU.0b013e3283641b86. Curr Opin Ophthalmol. 2013. PMID: 23872812 Review.
NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells.
Masters SL, Gerlic M, Metcalf D, Preston S, Pellegrini M, O'Donnell JA, McArthur K, Baldwin TM, Chevrier S, Nowell CJ, Cengia LH, Henley KJ, Collinge JE, Kastner DL, Feigenbaum L, Hilton DJ, Alexander WS, Kile BT, Croker BA. Masters SL, et al. Among authors: collinge je. Immunity. 2012 Dec 14;37(6):1009-23. doi: 10.1016/j.immuni.2012.08.027. Epub 2012 Dec 6. Immunity. 2012. PMID: 23219391 Free PMC article.
20 results